omega-n-methylarginine has been researched along with bq 3020 in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (bq 3020) | Trials (bq 3020) | Recent Studies (post-2010) (bq 3020) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 87 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizuka, T; Kurita, A; Suzuki, K; Takamizawa-Matsumoto, M | 1 |
1 other study(ies) available for omega-n-methylarginine and bq 3020
| Article | Year |
|---|---|
Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells.
Topics: Cell Culture Techniques; Drug Interactions; Drug Synergism; Endothelin-1; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; NF-kappa B; Nitric Oxide Synthase; omega-N-Methylarginine; Peptide Fragments; Proteins; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Umbilical Cord; Vascular Cell Adhesion Molecule-1 | 1999 |